{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T07:18:14Z","timestamp":1778397494317,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiotensin-converting enzyme inhibitors (ACEis) are beneficial in patients with chronic kidney disease (CKD). Yet, their clinical effects after kidney transplantation (KTx) remain ambiguous and local renin-angiotensin system (RAS) regulation including the \u2018classical\u2019 and \u2018alternative\u2019 RAS has not been studied so far. Here, we investigated both systemic and kidney allograft-specific intrarenal RAS using tandem mass-spectrometry in KTx recipients with or without established ACEi therapy (n\u2009=\u200948). Transplant patients were grouped into early (&lt;2 years), intermediate (2\u201312 years) or late periods after KTx (&gt;12 years). Patients on ACEi displayed lower angiotensin (Ang) II plasma levels (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) and higher levels of Ang I (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) and Ang-(1\u20137) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) compared to those without ACEi independent of graft vintage. Substantial intrarenal Ang II synthesis was observed regardless of ACEi therapy. Further, we detected maximal allograft Ang II synthesis in the late transplant vintage group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.005) likely as a consequence of increased allograft chymase activity (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.005). Finally, we could identify neprilysin (NEP) as the central enzyme of \u2018alternative RAS\u2019 metabolism in kidney allografts. In summary, a progressive increase of chymase-dependent Ang II synthesis reveals a transplant-specific distortion of RAS regulation after KTx with considerable pathogenic and therapeutic implications.<\/jats:p>","DOI":"10.1038\/s41598-019-46114-x","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T10:03:06Z","timestamp":1562320986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-082X","authenticated-orcid":false,"given":"Johannes J.","family":"Kovarik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7795-2726","authenticated-orcid":false,"given":"Christopher C.","family":"Kaltenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2289-4837","authenticated-orcid":false,"given":"Chantal","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5995-8753","authenticated-orcid":false,"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7262-8954","authenticated-orcid":false,"given":"Marlies","family":"Antlanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2507-1377","authenticated-orcid":false,"given":"Johannes","family":"Werzowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-6149","authenticated-orcid":false,"given":"Farsad","family":"Eskandary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2428-543X","authenticated-orcid":false,"given":"Renate","family":"Kain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3144-8783","authenticated-orcid":false,"given":"Marko","family":"Poglitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2268-7766","authenticated-orcid":false,"given":"Sabine","family":"Schmaldienst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7600-912X","authenticated-orcid":false,"given":"Georg A.","family":"B\u00f6hmig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2316-449X","authenticated-orcid":false,"given":"Marcus D.","family":"S\u00e4emann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"46114_CR1","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1097\/HJH.0b013e32834bd1e7","volume":"29","author":"C Chatzikyrkou","year":"2011","unstructured":"Chatzikyrkou, C. et al. Pathogenesis and management of hypertension after kidney transplantation. J Hypertens 29, 2283\u20132294 (2011).","journal-title":"J Hypertens"},{"key":"46114_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/01.tp.0000437676.32082.fc","volume":"97","author":"G Wong","year":"2014","unstructured":"Wong, G., Lim, W. H. & Chapman, J. R. Questioning the myth: benefits of renin-angiotensin system blockade in kidney transplant recipients. Transplantation 97, 271\u2013272 (2014).","journal-title":"Transplantation"},{"key":"46114_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1681\/ASN.2005090955","volume":"17","author":"G Heinze","year":"2006","unstructured":"Heinze, G. et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 17, 889\u2013899 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"46114_CR4","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1681\/ASN.2006050543","volume":"17","author":"G Opelz","year":"2006","unstructured":"Opelz, G., Zeier, M., Laux, G., Morath, C. & Dohler, B. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 17, 3257\u20133262 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"46114_CR5","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","volume":"7","author":"S Hiremath","year":"2007","unstructured":"Hiremath, S., Fergusson, D., Doucette, S., Mulay, A. V. & Knoll, G. A. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 7, 2350\u20132360 (2007).","journal-title":"Am J Transplant"},{"key":"46114_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/TP.0000000000000139","volume":"97","author":"G Opelz","year":"2014","unstructured":"Opelz, G. & Dohler, B. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers. Transplantation 97, 310\u2013315 (2014).","journal-title":"Transplantation"},{"key":"46114_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S2213-8587(15)00368-X","volume":"4","author":"GA Knoll","year":"2016","unstructured":"Knoll, G. A. et al. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol 4, 318\u2013326 (2016).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"46114_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrneph.2015.201","volume":"12","author":"RD Toto","year":"2016","unstructured":"Toto, R. D. Transplantation: The role of RAAS blockade in kidney transplantation. Nat Rev Nephrol 12, 129\u2013131 (2016).","journal-title":"Nat Rev Nephrol"},{"key":"46114_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/TP.0000000000001140","volume":"100","author":"NB Cross","year":"2016","unstructured":"Cross, N. B. & Webster, A. C. Angiotensin-Converting Enzyme Inhibitors-Beneficial Effects Seen in Many Patient Groups May Not Extend to Kidney Transplant Recipients. Transplantation 100, 472\u2013473 (2016).","journal-title":"Transplantation"},{"key":"46114_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/1947-2714.187141","volume":"8","author":"W Cheungpasitporn","year":"2016","unstructured":"Cheungpasitporn, W. et al. The Effect of Renin-angiotensin System Inhibitors on Kidney Allograft Survival: A Systematic Review and Meta-analysis. N Am J Med Sci 8, 291\u2013296 (2016).","journal-title":"N Am J Med Sci"},{"key":"46114_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ki.2013.278","volume":"85","author":"N Issa","year":"2014","unstructured":"Issa, N. et al. The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure. Kidney Int 85, 404\u2013415 (2014).","journal-title":"Kidney Int"},{"key":"46114_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1681\/ASN.2010040384","volume":"22","author":"C Ruster","year":"2011","unstructured":"Ruster, C. & Wolf, G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 22, 1189\u20131199 (2011).","journal-title":"J Am Soc Nephrol"},{"key":"46114_CR13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1517\/14656566.8.5.529","volume":"8","author":"VG Athyros","year":"2007","unstructured":"Athyros, V. G., Mikhailidis, D. P., Kakafika, A. I., Tziomalos, K. & Karagiannis, A. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution? Expert Opin Pharmacother 8, 529\u2013535 (2007).","journal-title":"Expert Opin Pharmacother"},{"key":"46114_CR14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/00005344-198211000-00014","volume":"4","author":"J Biollaz","year":"1982","unstructured":"Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B. & Gavras, H. Antihypertensive therapy with MK 421: angiotensin II\u2013renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 4, 966\u2013972 (1982).","journal-title":"J Cardiovasc Pharmacol"},{"key":"46114_CR15","doi-asserted-by":"publisher","first-page":"F35","DOI":"10.1152\/ajprenal.00641.2009","volume":"298","author":"JN Lorenz","year":"2010","unstructured":"Lorenz, J. N. Chymase: the other ACE? Am J Physiol Renal Physiol 298, F35\u201336 (2010).","journal-title":"Am J Physiol Renal Physiol"},{"key":"46114_CR16","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJMe0908183","volume":"361","author":"JR Ingelfinger","year":"2009","unstructured":"Ingelfinger, J. R. Blood-pressure control and delay in progression of kidney disease in children. N Engl J Med 361, 1701\u20131703 (2009).","journal-title":"N Engl J Med"},{"key":"46114_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.healun.2016.08.022","volume":"36","author":"JJ Kovarik","year":"2017","unstructured":"Kovarik, J. J. et al. Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients. J Heart Lung Transplant 36, 355\u2013365 (2017).","journal-title":"J Heart Lung Transplant"},{"key":"46114_CR18","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1046\/j.1523-1755.2001.0590041374.x","volume":"59","author":"M Yamada","year":"2001","unstructured":"Yamada, M. et al. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int 59, 1374\u20131381 (2001).","journal-title":"Kidney Int"},{"key":"46114_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1254\/jphs.09152FP","volume":"111","author":"YY Fan","year":"2009","unstructured":"Fan, Y. Y. et al. Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters. J Pharmacol Sci 111, 82\u201390 (2009).","journal-title":"J Pharmacol Sci"},{"key":"46114_CR20","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1097\/01.ASN.0000071512.93927.4E","volume":"14","author":"XR Huang","year":"2003","unstructured":"Huang, X. R., Chen, W. Y., Truong, L. D. & Lan, H. Y. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol 14, 1738\u20131747 (2003).","journal-title":"J Am Soc Nephrol"},{"key":"46114_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","volume":"11","author":"F Jiang","year":"2014","unstructured":"Jiang, F. et al. Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Nat Rev Cardiol 11, 413\u2013426 (2014).","journal-title":"Nat Rev Cardiol"},{"key":"46114_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ki.2014.274","volume":"87","author":"K Zhang","year":"2015","unstructured":"Zhang, K. et al. Angiotensin(1\u20137) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade. Kidney Int 87, 359\u2013369 (2015).","journal-title":"Kidney Int"},{"key":"46114_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep33678","volume":"6","author":"O Domenig","year":"2016","unstructured":"Domenig, O. et al. Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney. Sci Rep 6, 33678 (2016).","journal-title":"Sci Rep"},{"key":"46114_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ki.2015.107","volume":"88","author":"LC Roksnoer","year":"2015","unstructured":"Roksnoer, L. C. et al. Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats. Kidney Int 88, 109\u2013120 (2015).","journal-title":"Kidney Int"},{"key":"46114_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","volume":"69","author":"R Basu","year":"2017","unstructured":"Basu, R. et al. Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure. J Am Coll Cardiol 69, 805\u2013819 (2017).","journal-title":"J Am Coll Cardiol"},{"key":"46114_CR26","doi-asserted-by":"publisher","first-page":"e85323","DOI":"10.1172\/jci.insight.85323","volume":"1","author":"JM Venner","year":"2016","unstructured":"Venner, J. M., Famulski, K. S., Reeve, J., Chang, J. & Halloran, P. F. Relationships among injury, fibrosis, and time in human kidney transplants. JCI Insight 1, e85323 (2016).","journal-title":"JCI Insight"},{"key":"46114_CR27","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"J Sellares","year":"2012","unstructured":"Sellares, J. et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12, 388\u2013399 (2012).","journal-title":"Am J Transplant"},{"key":"46114_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1053\/j.ajkd.2016.08.018","volume":"69","author":"S Hiremath","year":"2017","unstructured":"Hiremath, S., Fergusson, D. A., Fergusson, N., Bennett, A. & Knoll, G. A. Renin-Angiotensin System Blockade and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Meta-analysis of Randomized Controlled Trials. Am J Kidney Dis 69, 78\u201386 (2017).","journal-title":"Am J Kidney Dis"},{"key":"46114_CR29","doi-asserted-by":"publisher","first-page":"147032031770523","DOI":"10.1177\/1470320317705232","volume":"18","author":"M Antlanger","year":"2017","unstructured":"Antlanger, M. et al. Molecular remodeling of the renin-angiotensin system after kidney transplantation. J Renin Angiotensin Aldosterone Syst 18, 1470320317705232 (2017).","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"46114_CR30","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cphy.c130040","volume":"4","author":"MA Sparks","year":"2014","unstructured":"Sparks, M. A., Crowley, S. D., Gurley, S. B., Mirotsou, M. & Coffman, T. M. Classical Renin-Angiotensin system in kidney physiology. Compr Physiol 4, 1201\u20131228 (2014).","journal-title":"Compr Physiol"},{"key":"46114_CR31","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1681\/ASN.2016070734","volume":"28","author":"T Yang","year":"2017","unstructured":"Yang, T. & Xu, C. Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: An Update. J Am Soc Nephrol 28, 1040\u20131049 (2017).","journal-title":"J Am Soc Nephrol"},{"key":"46114_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.ackd.2014.11.004","volume":"22","author":"RM Carey","year":"2015","unstructured":"Carey, R. M. The intrarenal renin-angiotensin system in hypertension. Adv Chronic Kidney Dis 22, 204\u2013210 (2015).","journal-title":"Adv Chronic Kidney Dis"},{"key":"46114_CR33","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/HJH.0b013e3283392673","volume":"28","author":"H Kobori","year":"2010","unstructured":"Kobori, H., Urushihara, M., Xu, J. H., Berenson, G. S. & Navar, L. G. Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). J Hypertens 28, 1422\u20131428 (2010).","journal-title":"J Hypertens"},{"key":"46114_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1470320314557584","volume":"15","author":"Y Nishijima","year":"2014","unstructured":"Nishijima, Y. et al. Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers and in patients with chronic kidney disease. J Renin Angiotensin Aldosterone Syst 15, 505\u2013508 (2014).","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"46114_CR35","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.transproceed.2013.11.088","volume":"46","author":"T Naganuma","year":"2014","unstructured":"Naganuma, T. et al. Investigation of urinary angiotensinogen in renal transplant recipients. Transplant Proc 46, 489\u2013491 (2014).","journal-title":"Transplant Proc"},{"key":"46114_CR36","first-page":"F902","volume":"262","author":"J Fox","year":"1992","unstructured":"Fox, J., Guan, S., Hymel, A. A. & Navar, L. G. Dietary Na and ACE inhibition effects on renal tissue angiotensin I and II and ACE activity in rats. Am J Physiol 262, F902\u2013909 (1992).","journal-title":"Am J Physiol"},{"key":"46114_CR37","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1016\/j.transproceed.2005.10.099","volume":"37","author":"JE Fildes","year":"2005","unstructured":"Fildes, J. E. et al. The effects of ACE inhibition on serum angiotensin II concentration following cardiac transplantation. Transplant Proc 37, 4525\u20134527 (2005).","journal-title":"Transplant Proc"},{"key":"46114_CR38","first-page":"125","volume":"3","author":"C Schindler","year":"2007","unstructured":"Schindler, C., Bramlage, P., Kirch, W. & Ferrario, C. M. Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag 3, 125\u2013137 (2007).","journal-title":"Vasc Health Risk Manag"},{"key":"46114_CR39","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/ndt\/gfw071","volume":"31","author":"JJ Kovarik","year":"2016","unstructured":"Kovarik, J. J. et al. Molecular regulation of the renin-angiotensin system in haemodialysis patients. Nephrol Dial Transplant 31, 851 (2016).","journal-title":"Nephrol Dial Transplant"},{"key":"46114_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11906-014-0429-9","volume":"16","author":"S Ahmad","year":"2014","unstructured":"Ahmad, S. et al. Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate. Curr Hypertens Rep 16, 429 (2014).","journal-title":"Curr Hypertens Rep"},{"key":"46114_CR41","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1097\/01.ASN.0000026610.48842.CB","volume":"13","author":"A Nishiyama","year":"2002","unstructured":"Nishiyama, A., Seth, D. M. & Navar, L. G. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 13, 2207\u20132212 (2002).","journal-title":"J Am Soc Nephrol"},{"key":"46114_CR42","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1600-6143.2008.02462.x","volume":"9","author":"M Mengel","year":"2009","unstructured":"Mengel, M. et al. Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant 9, 169\u2013178 (2009).","journal-title":"Am J Transplant"},{"key":"46114_CR43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1399-0012.2005.00427.x","volume":"19","author":"T Ishida","year":"2005","unstructured":"Ishida, T. et al. Mast cell numbers and protease expression patterns in biopsy specimens following renal transplantation from living-related donors predict long-term graft function. Clin Transplant 19, 817\u2013824 (2005).","journal-title":"Clin Transplant"},{"key":"46114_CR44","doi-asserted-by":"publisher","first-page":"e0162644","DOI":"10.1371\/journal.pone.0162644","volume":"11","author":"G Sansoe","year":"2016","unstructured":"Sansoe, G. et al. Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data. PLoS One 11, e0162644 (2016).","journal-title":"PLoS One"},{"key":"46114_CR45","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/978-1-4419-9533-9_12","volume":"716","author":"GH Caughey","year":"2011","unstructured":"Caughey, G. H. Mast cell proteases as protective and inflammatory mediators. Adv Exp Med Biol 716, 212\u2013234 (2011).","journal-title":"Adv Exp Med Biol"},{"key":"46114_CR46","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1161\/01.CIR.0000074786.92067.AA","volume":"107","author":"JO Kokkonen","year":"2003","unstructured":"Kokkonen, J. O., Lindstedt, K. A. & Kovanen, P. T. Role for chymase in heart failure: angiotensin II-dependent or -independent mechanisms? Circulation 107, 2522\u20132524 (2003).","journal-title":"Circulation"},{"key":"46114_CR47","doi-asserted-by":"crossref","unstructured":"Ansary, T. M. et al. Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice. Exp Physiol (2018).","DOI":"10.1113\/EP087209"},{"key":"46114_CR48","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s11906-014-0420-5","volume":"16","author":"J Varagic","year":"2014","unstructured":"Varagic, J., Ahmad, S., Nagata, S. & Ferrario, C. M. ACE2: angiotensin II\/angiotensin-(1-7) balance in cardiac and renal injury. Curr Hypertens Rep 16, 420 (2014).","journal-title":"Curr Hypertens Rep"},{"key":"46114_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/01.HYP.31.1.362","volume":"31","author":"MC Chappell","year":"1998","unstructured":"Chappell, M. C., Pirro, N. T., Sykes, A. & Ferrario, C. M. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 31, 362\u2013367 (1998).","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"46114_CR50","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1097\/01.hjh.0000467659.31038.0f","volume":"33","author":"O Domenig","year":"2015","unstructured":"Domenig, O. et al. 8d.05: The Role of Neprilysin in Angiotensin 1-7 Formation in the Kidney. J Hypertens 33(Suppl 1), e114\u2013115 (2015).","journal-title":"J Hypertens"},{"key":"46114_CR51","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1681\/ASN.2012080777","volume":"24","author":"HN Ibrahim","year":"2013","unstructured":"Ibrahim, H. N. et al. Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 24, 320\u2013327 (2013).","journal-title":"J Am Soc Nephrol"},{"key":"46114_CR52","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray, J. J., Packer, M. & Solomon, S. D. Neprilysin inhibition for heart failure. N Engl J Med 371, 2336\u20132337 (2014).","journal-title":"N Engl J Med"},{"key":"46114_CR53","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1183\/09031936.00018215","volume":"46","author":"D Kosanovic","year":"2015","unstructured":"Kosanovic, D. et al. Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis. Eur Respir J 46, 1084\u20131094 (2015).","journal-title":"Eur Respir J"},{"key":"46114_CR54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","volume":"6","author":"K Damman","year":"2018","unstructured":"Damman, K. et al. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC Heart Fail 6, 489\u2013498 (2018).","journal-title":"JACC Heart Fail"},{"key":"46114_CR55","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2213-8587(18)30100-1","volume":"6","author":"M Packer","year":"2018","unstructured":"Packer, M. et al. Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial. Lancet Diabetes Endocrinol 6, 547\u2013554 (2018).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"46114_CR56","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1111\/ajt.13661","volume":"16","author":"M Haas","year":"2016","unstructured":"Haas, M. The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations. Am J Transplant 16, 1352\u20131357 (2016).","journal-title":"Am J Transplant"},{"key":"46114_CR57","unstructured":"CW, C., PP, E:. Methods of Dealing with Values Below the Limit of Detection using SAS. analytics.ncsu.edu\/sesug\/2003\/SD08-Croghan.pdf (2003)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46114-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46114-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:17:22Z","timestamp":1671275842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46114-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46114"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46114-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9762"}}